CCI Shouldn’t Intervene Without Clear Anti-competitive Conduct

Somnath Banerjee Vs Apex Lab (Competition Commission of India)

The Competition Commission of India (CCI) recently addressed a complaint filed by Mr. Somnath Banerjee against various entities in the pharmaceutical industry, alleging violations of competition laws. The complaint centered around the marketing and promotion practices of his patented dietary supplement, ‘Protestin,’ sold by Reserca Health Care Pvt. Ltd. This article delves into the details of the case, the arguments presented, and the CCI’s ruling.

Mr. Somnath B

Please become a Premium member. If you are already a Premium member, login here to access the full content.